Mittal Rakesh, Mittal Niti, Hota Debasish, Suri Vanita, Aggarwal Neelam, Chakrabarti Amitava
Department of Pharmacology, Pt B D Sharma Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India.
Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Int J Appl Basic Med Res. 2014 Jan;4(1):28-33. doi: 10.4103/2229-516X.125686.
One of the postulated mechanism for cardioprotective potential of isoflavones is their ability to exert antioxidant action. However, various reports give conflicting results in this area.
The present study was conducted with an objective to probe into the cardioprotective mechanism of isoflavones by evaluating their antioxidant potential in oophorectomized women.
This was a randomized, double-blind, parallel, placebo controlled study. A total of 43 women were randomized to receive 75 mg/day isoflavones tablet or placebo for 12 weeks. Red blood cell antioxidant parameters including lipid peroxidation, superoxide dismutase (SOD), catalase and glutathione peroxidase (GSH-Px) were determined at baseline and at the end of the study.
After 12 weeks of administration of isoflavones, there was no statistically significant difference in lipid peroxidation (P value for isoflavones: 0.37; for placebo: 0.37), catalase (P value for isoflavones: 0.35; for placebo: 0.84), SOD (P value for isoflavones: 0.41; for placebo: 0.28) and GSH-Px (P value for isoflavones: 0.92; for placebo: 0.29). There was no statistically significant difference in the proportion of patients experiencing adverse events in the two groups (P -1.00).
The study strengthens the concept that the cardioprotective mechanism of isoflavones might be due to some other reason apart from the antioxidant pathway.
异黄酮具有心脏保护作用的一种假定机制是其具有抗氧化作用。然而,该领域的各种报告给出了相互矛盾的结果。
本研究旨在通过评估异黄酮对去卵巢女性的抗氧化潜力,探讨其心脏保护机制。
这是一项随机、双盲、平行、安慰剂对照研究。总共43名女性被随机分为两组,分别接受每日75毫克异黄酮片或安慰剂,为期12周。在基线和研究结束时测定红细胞抗氧化参数,包括脂质过氧化、超氧化物歧化酶(SOD)、过氧化氢酶和谷胱甘肽过氧化物酶(GSH-Px)。
服用异黄酮12周后,脂质过氧化(异黄酮P值:0.37;安慰剂P值:0.37)、过氧化氢酶(异黄酮P值:0.35;安慰剂P值:0.84)、SOD(异黄酮P值:0.41;安慰剂P值:0.28)和GSH-Px(异黄酮P值:0.92;安慰剂P值:0.29)方面均无统计学显著差异。两组中出现不良事件的患者比例也无统计学显著差异(P值为1.00)。
该研究强化了这样一种观念,即异黄酮的心脏保护机制可能并非源于抗氧化途径,而是另有原因。